— Know what they know.
Not Investment Advice

SION NASDAQ

Sionna Therapeutics, Inc.
1W: -2.4% 1M: -3.4% 3M: +17.6% YTD: +6.5% 1Y: +198.0%
$41.13
-0.62 (-1.49%)
 
Weekly Expected Move ±10.8%
$32 $36 $40 $45 $49
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 48 · $1.9B mcap · 26M float · 1.42% daily turnover · Short 73% of daily vol

Balance Sheet Trends

Total Assets
$326M +75.5% ▲
3Y CAGR: +55.1%
Total Liabilities
$19M -94.5% ▼
3Y CAGR: -50.5%
Shareholders Equity
$307M +287.4% ▲
Cash & Investments
$236M +59.9% ▲
3Y CAGR: +41.9%
Total Debt
$9M -11.0% ▼
Net Debt
-$50M -77.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$55M$39M$38M$58M
Short-Term Investments$28M$0$110M$177M
Cash & ST Investments$83M$39M$148M$236M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$1M$686K$3M$6M
Total Current Assets$84M$39M$151M$241M
Property, Plant & Equip.$3M$12M$10M$9M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$21M$0
Other Non-Current Assets$962K$1M$4M$75M
Total Non-Current Assets$4M$13M$35M$85M
Total Assets$87M$52M$186M$326M
— Liabilities —
Accounts Payable$557K$719K$1M$769K
Short-Term Debt$0$0$0$0
Deferred Revenue$0$0$0$0
Other Current Liabilities$2M$3M$3M$10M
Total Current Liabilities$8M$8M$10M$12M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$149M$149M$330M$0
Total Non-Current Liabilities$149M$159M$339M$7M
Total Liabilities$157M$167M$349M$19M
— Equity —
Common Stock$2K$2K$5K$45K
Retained Earnings-$72M-$119M-$181M-$256M
Accumulated OCI-$16K$0$368K$540K
Total Stockholders Equity-$70M-$115M-$164M$307M
Total Liabilities & Equity$87M$52M$186M$326M
— Key Metrics —
Total Debt$0$10M$10M$9M
Net Debt-$55M-$28M-$28M-$50M
Total Investments$28M$0$130M$177M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms